Integration of Molecular Diagnostics and Biomarkers Improving Lynch Syndrome Detection
The global lynch syndrome market is growing steadily as awareness of hereditary cancer syndromes increases, genetic testing becomes more accessible, and early intervention strategies gain traction in clinical practice. According to market estimates, the Lynch Syndrome market—valued at around USD 1,552 million in 2022—is projected to reach approximately USD...
0 Condivisioni
32 Visualizzazioni